Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 3 | ClinicalTrials |
| Breast Neoplasms | Phase 3 | ClinicalTrials |
| Urinary Bladder Neoplasms | Phase 3 | ClinicalTrials |
| Carcinoma, Renal Cell; Kidney Neoplasms | Phase 2 | ClinicalTrials |
| Lung Neoplasms; Small Cell Lung Carcinoma | Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Germ Cell and Embryonal; Neoplasms, Plasma Cell; Plasmacytoma | Phase 1 | ClinicalTrials |
| Prostatic Neoplasms | Phase 1 | ClinicalTrials |
| Lymphoma | Phase 2 | ClinicalTrials |
| Lymphoma | Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms; Neoplasms, Plasma Cell; Plasmacytoma | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Lymphoma | Phase 2 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 2 | ClinicalTrials |
CONTENTS